We next ascertained whether Egln3H196A affected the kinetics of tumor progression by injecting Hu-glioma cells expressing Egln3 or Egln3H196A under the control of a Dox-inducible promoter into the flanks of NSG mice. This evidence concerns the gene EGLN3 and central nervous system cancer.